Research
Peptide research, explained without the sales pitch
301 articles on what the evidence actually shows for compounded peptides, GLP-1s and the research-vial market — separate from any single provider's marketing.
- 301Articles
- 1,322Sources cited
- 16Compounds discussed
- 56Publishers cited
All research articles
Research
CJC-1295 and ipamorelin, explained
The two compounds raise growth hormone through different receptors, and that part is real pharmacology. But the version of CJC-1295 most commonly sold is not the version that went through human trials, and the pairing itself has never been tested for the results it is sold on.
Research
Compounded semaglutide and tirzepatide: what the shortage rule allowed, and why it changed
For about two years, a pharmacy could legally compound a copy of an approved GLP-1 drug because the approved product was in short supply. That exception was always temporary by design, and it ended for both drugs on a specific, dated timeline that is worth knowing before reading anything a seller says about "legal compounded semaglutide" today.
Research
Tirzepatide vs. semaglutide: what the head-to-head trial found
The two most-searched compounds in this market have actually been tested against each other, directly, in the same randomized trial. That is rare in this field and worth reading carefully, including the parts of the trial's design that a headline weight-loss number leaves out.
Research
BPC-157: what the evidence shows
BPC-157 is the most searched compound in this market and one of the least tested in people. The rodent literature is large and genuinely interesting. The human record is four registered studies with no results posted and a regulator that could not find a single study giving it by the routes it is sold in.
Research
Epitalon: what the evidence shows
Search Epitalon and you will find five controlled trials. Open them and every one studies a different substance: a pineal gland extract called Epithalamin, not the four-amino-acid synthetic sold under the Epitalon name. Split the two search terms and the trial count for Epitalon is zero.
Research
GHK-Cu: what it is and what is actually known
GHK-Cu has a large and genuinely interesting laboratory literature behind it. Almost none of it was produced by injecting the compound into people, which is the way it is now being sold.
Research
Glutathione injections: what is known
Glutathione is a real molecule doing real work inside every cell you have. None of that is evidence that injecting more of it lightens skin, clears toxins or raises energy, and the human trials that would settle those claims have not been done.
Research
KPV: what the evidence shows
KPV is sold as the working end of an anti-inflammatory hormone. The laboratory work FDA reviewed says it does not bind the receptors that hormone acts through. Nobody has published a study giving it to a person, and the products on sale are injectables and capsules while regulators were shown a topical cream.
Research
MOTS-c: what the evidence shows
MOTS-c is a peptide your mitochondria already make, and the human research on it is real. Almost all of that research measures how much of it your own body releases. Studies that inject it into people and report an outcome are a different thing, and until 2026 there were none.
Research
NAD+ injections, IV drips and oral precursors: what actually differs
The three delivery routes are not three strengths of the same product. The oral precursors are the ones with real human pharmacology behind them, and the intravenous drip that costs the most has the least published support for the results it is sold on.
Research
PT-141: what the research actually covers
Bremelanotide is a real FDA-approved drug with randomized trial evidence behind one narrow indication in one population. Almost nothing sold as PT-141 is that product, for that indication, in that population.
Research
Semaglutide: what the evidence shows
Semaglutide is graded strong evidence on this site, and it earns that grade honestly: randomized trials, an FDA review, and a label with a boxed warning. What the grade does not do is follow the name onto every vial sold under it, because a meaningful share of what is marketed as semaglutide is not the approved product at all.
Research
Semax: what the evidence shows
Semax is a registered medicine in Russia and a research chemical in the United States. That is not a contradiction, and it is the reason its evidence base is so hard to read from here. Most of the human record is in a language a US regulator could not formally consider.
Research
Sermorelin: what the evidence actually shows
Sermorelin genuinely moves the growth hormone axis, which is why it was once an approved diagnostic agent. But the trials that would show it changes how a healthy adult looks, sleeps, recovers or ages have not been done.
Research
TB-500 and thymosin beta-4 are not the same molecule
Sellers cite thymosin beta-4 trials on a TB-500 product page. Thymosin beta-4 is a protein of 43 amino acids that has been through phase 1 and phase 2 human trials. TB-500 is a seven-amino-acid fragment of it, and the trial evidence does not transfer.
Research
Tesamorelin: what the evidence covers
Tesamorelin is one of the few compounds in this market with an FDA-approved product behind it. The approval covers a narrow problem in a specific group of patients, and that is usually not the reason it is being offered.
Research
Tirzepatide: what the evidence shows
Tirzepatide is the most-searched compound in this entire market and, unlike almost everything else covered here, it earned an FDA approval through randomized trials rather than search volume. That approval is specific: to a product, a dose range and a population. Reading past the brand name is the whole point of what follows.
Research
NAD+: what the evidence shows
The human research in this category is real, and most of it is about capsules. A systematic review of the whole field states that no eligible outcomes trial has tested intravenous or intramuscular NAD+ itself for the aging and wellness uses it is sold for. The one placebo-controlled trial of NAD+ given by vein studied hospital patients with heart failure.
Research
How long an unpaid bill stays on a credit file
The statute sets outer periods rather than a single answer, and the period for a collection account is measured from a point most people do not expect. A separate provision keeps the identity of a medical information furnisher out of a report unless it is coded.
Research
The amounts a collector may not add to a debt
One sentence in the collection rules does most of the work on money. A collector may not collect any amount unless it is expressly authorized by the agreement that created the debt or permitted by law, and that test covers interest, fees, charges and expenses alike.
Research
The debt that can no longer be sued on
When the period for bringing an action has run, a debt collector may not sue and may not threaten to sue. The prohibition is short and absolute, but it removes one remedy rather than the obligation, and the rule takes the period itself from other law rather than setting one.
Research
The floor under a medical expense deduction
The statute allows a deduction only for the part of medical care expenses above a percentage of adjusted gross income, only for amounts not compensated by insurance or otherwise, and only for drugs that were prescribed. Each of those three limits is doing separate work.
Research
The invoice a medical expense claim rests on
The regulation on substantiation asks for something a payment receipt does not contain. It wants a statement or itemised invoice from the party that was paid, describing the nature of the service and for whom it was rendered, alongside the amount and the date.
Research
The records behind a cash-paid health purchase
The recordkeeping rule does not name a document or a number of years. It sets a sufficiency standard and a materiality standard, and both of them are answered by what a record can establish rather than by how long it has been kept.
Research
What a collector is not allowed to say
The rules against false and abusive collection are written as a general prohibition followed by a long list of specifics. The list is the useful part, because it names the exact impressions a collector may not create and attaches a numerical presumption to how often a telephone may ring.
Research
What a credit file dispute sets in motion
A dispute sent to a consumer reporting agency starts two parallel obligations with a shared deadline: the agency has to reinvestigate, and the furnisher it notifies has to investigate too. The statute also governs what happens after, including the certification required before deleted information can come back.
Research
What a flexible spending account asks you to prove
The published guidance sets out two written statements before a health flexible spending arrangement reimburses anything. One has to come from an independent third party and say the expense was incurred and how much it was. The other has to say it was not covered elsewhere.
Research
What a health savings account may be spent on
The account rules point straight back at the medical care definition in the deduction statute, then add three conditions of their own: the expense must not have been compensated, must have been incurred after the account existed, and cannot be deducted as well.
Research
What a written dispute of a debt stops
A dispute in writing, delivered inside a defined window, obliges a debt collector to stop collecting until it sends verification. That is a pause with a condition attached rather than a cancellation, and the difference between the two is where most misunderstanding of this rule lives.
Research
What has to happen before a debt reaches a credit file
Furnishing information about a debt to a credit reporting agency is not a free act. A collector has to have made contact first, and any furnisher carries standing duties about accuracy, about disputes, and about the one date that sets how long the item can stay.
Research
When and where a collector may make contact
The federal rules on debt collection communications are unusually concrete. They fix a default window of hours, name the places contact may not happen, close the list of people who may be told anything, and set out how a consumer ends the contact entirely.
Research
How a complaint against a licensee is filed
Two very different things reach a health board under the same word. One is a complaint anybody may write. The other is a report an employer is required by statute to send, on a clock, whether anyone complained or not.
Research
The clock on an electronic transfer dispute
A notice of error about money that left a bank account starts a timetable written in days, not a negotiation. The rule sets what the consumer has to say, how long the institution has to answer, and when money goes back into the account while the answer is still being worked out.
Research
The consent a telehealth visit has to record
One state requires a clinician to obtain and document a patient's agreement to telehealth itself, before anything else happens, and makes failing to do so unprofessional conduct. It is a narrower consent than most readers assume.
Research
The notice that has to arrive when a debt is handed over
A debt collector cannot simply ask for money. Federal rules require a defined package of information to reach the consumer in the first communication or within days of it, and the package is specified down to the reference date the amount is measured from and the wording of the response prompts.
Research
The store credit that is not a refund
Money returned as credit on the seller's own account is a different instrument from money returned to the card. A federal rule caps how fast such a balance may erode and how soon it may expire, but only for devices that fall inside its definitions, and its exclusion list is long enough to decide most cases.
Research
What a board can order after a finding
Revocation is the one everybody names and the one that is rarely first. The statutory menu is longer than that, the order in which a board is told to think about it is written down, and departing from the schedule requires an explanation in writing.
Research
What a license renewal actually requires
Renewal is the point at which a board looks again, and the statutes describe it as a scheduled re-decision rather than a payment. What it asks for varies by state, by profession and by the kind of license.
Research
What a nurse licensure compact changes
A compact does not make one license work everywhere. It creates a privilege attached to a home-state license, subjects the holder to the practice laws of wherever the patient is, and wires the states' investigation files together.
Research
What a payment receipt has to show, and what it may not print
Two different federal rules touch the slip of paper or the email that follows a payment. One sets out what a receipt for an electronic transfer has to contain. The other limits how much of a card number may appear on it. Neither one obliges a seller to itemise what was actually bought.
Research
What a pharmacist may initiate under a protocol
One state lets a pharmacist start or adjust a drug regimen without a new prescription, but only inside a written protocol built by a named group, only for a patient a physician has already seen, and only with notice back within a day.
Research
What a practice agreement with a physician covers
In one state, a nurse practitioner or physician assistant who has not yet earned autonomous practice works under a written agreement that names a physician, sets the prescribing scope and comes with a disclosure the patient can ask for by name.
Research
What a state publishes about its licensees
Two states write down exactly what has to appear on a public license record, and the lists are long. What is missing from them is written down too, which is the part that decides how far a lookup can be read.
Research
What a state requires before a first online prescription
Federal law is not the only thing standing between an intake form and a prescription. Two state codes set out what a prescriber must have done first, and they answer the question about live video very differently.
Research
What an audio-only visit counts as
One state defines a telephone consultation in statute, attaches a prior-relationship condition to it, and requires consent before it can be billed. The definitions are narrower than they look, and so is the section they sit in.
Research
What becomes public after a board complaint
Most of a disciplinary file is confidential by statute, and the point at which that changes is a specific document rather than a stage of the investigation. Two kinds of settlement look identical and are treated as opposites.
Research
What has to be disclosed before a credit sale closes
Where an installment purchase is closed-end consumer credit, a defined set of terms has to reach the buyer in writing, grouped together and before the deal is done. The list is specific, two of its items have to be printed more conspicuously than the rest, and an online order gets a named exception on timing.
Research
What unprofessional conduct actually covers
The phrase sounds like bedside manner. In the three state codes read here it is a long enumerated list that reaches record-keeping, advertising, supervision, cooperation with the regulator and the promotion of unnecessary treatment.
Research
When a payment plan is credit, and when it is not
Splitting a price into installments does not automatically bring a purchase inside the consumer credit rules. Two tests decide it: whether a finance charge is imposed, and whether the obligation is payable by written agreement in more than four installments. A plan that fails both sits outside the disclosure regime entirely.
Research
Where business control stops and professional judgment begins
Owning a health business and directing a clinical decision are different acts, and several state codes draw the line by naming the specific decision an owner may not touch rather than by restricting ownership itself.
Research
Who is allowed to own a medical practice
One state's code opens the question with a single sentence denying corporations any professional powers at all. Another expressly protects an employing company's position. The gap between those two is where a great deal of health business structuring happens.
Research
Who the debt collection rules actually reach
The federal debt collection rules are built around a defined term, and the term does not mean anyone who asks for money. It turns on whose debt is being collected, whose name is being used, and whether the debt was in default when the collector got it. Most of the protections travel with that classification.
Research
The permit a pharmacy needs to ship into another state
A pharmacy that mails a prescription across a state line is regulated by the state it ships into as well as the state it sits in. Three states describe that second license very differently, and the differences are the interesting part.
Research
What a compounding pharmacy has to report to a state
California puts several different clocks on a sterile compounder, and they are not the same clock. Ten days for what another regulator did, twelve hours for a recall, and a separate set of numbers entirely for an outsourcing facility.
Research
What a state board of pharmacy actually licenses
A pharmacy license attaches to an address and, in some states, to a named pharmacist rather than to the business behind it. That distinction decides who answers when something goes wrong.
Research
What a state sterile compounding license adds
In California, a pharmacy that compounds sterile preparations holds a second license on top of its pharmacy license, and that second one cannot be issued until an inspector has been inside the room.
Research
The identifier a device package has to carry
Medical devices carry a two-part code on the label, one half naming the model and the other naming the batch. The rule behind it also builds a public database, and it says who has to keep that database honest.
Research
The reagent a laboratory builds its own test from
Some laboratories assemble their own tests out of restricted components. The rule governing those components names who they may be sold to, and it puts a specific sentence at the bottom of every report the resulting test produces.
Research
What a diagnostic test kit has to tell you
The paper inside a diagnostic product is not a courtesy. Federal regulation fixes fifteen items and the order they appear in, and four of them are the ones a reader should look for first.
Research
How a substance gets onto a controlled schedule
The five schedules are not a fixed list. Statute sets out how something is added, moved or removed, which findings each schedule demands, and one point at which the health department can stop the process outright.
Research
The declaration a traveler carrying medicine has to make
A narrow exemption lets an individual cross a border with a controlled medicine obtained lawfully for personal use. It is written as a list of conditions, and one of them is a specific declaration to a customs officer.
Research
The mark that says where a product was made
Foreign goods have to carry the English name of the country they came from, marked so it survives to the last person who receives it. The rule turns on who that person is, and it has a specific answer for packaging that mentions somewhere else.
Research
The needle and the syringe are regulated devices
Injection supplies are not accessories to a drug. Each one has its own classification regulation, its own risk class, and its own labeling rule, and the category they sit in decides who may be sold them.
Research
The permit behind an imported controlled substance
Bringing a scheduled substance into the country runs on a permit or a declaration, one per shipment, filed by a registered party. The rules also close the mail route for a named group of them.
Research
The records an importer has to keep
Bringing goods into the country creates a five-year paperwork duty, and it reaches further than the party who filed the entry. The rules also say who does not have it, in a sentence written about consumers.
Research
The storage rules a prescription drug travels under
Between the factory and the pharmacy sits a warehouse, and a federal rule sets the minimum standards a state licensing law has to impose on it. Temperature is one line of many, and the recordkeeping around it is the part with teeth.
Research
How an import alert works
An import alert lets shipments be detained without anyone opening a box. It runs on an appearance standard rather than a test result, and the lists inside it are read in a way that is easy to get backwards.
Research
The hearing before a shipment is refused entry
A refusal at the border is preceded by a written notice naming a place and a period to introduce testimony. The same statute also contains a route to destruction without any opportunity to export, and it turns on a dollar figure.
Research
What an import invoice has to state
Federal law lists the contents of the document that describes an imported shipment to Customs. It runs to eleven items, it has to be in English, and there is a separate procedure for the case where nobody can produce one.
Research
What customs may do with a parcel in the mail
All mail arriving from outside the country is subject to examination, with a short list of exceptions. The rules draw one sharp line, and it is around correspondence rather than around merchandise.
Research
What happens after a shipment is seized
Customs forfeiture runs on published notices and short clocks. The goods are valued, the seizure is advertised, and a claim has to be filed within twenty days to stop the process from finishing on its own.
Research
Why a mailed parcel and a courier parcel are not the same
Two separate parts of the customs rules govern the two routes. They ask for different data, from different parties, at different moments, and one of them currently has its duty-free threshold switched off.
Research
The marketing rules that name a private plaintiff
Most consumer rules name a government enforcer and stop there. The federal telephone statute is unusual: it names an individual, an amount, and a state official, in three separate provisions with three different triggers.
Research
What the Commission says about comparing brands by name
A short policy statement encourages advertisers to name competitors and then removes the excuse that usually follows. It sets no lower bar for proof, and it is addressed to the bodies that write industry codes rather than to sellers.
Research
When a company that sells facts about you is a reporting agency
Federal law defines a category of business that assembles information about people and sells it, and then restricts who may receive the result. The definition is narrower than data broker and wider than credit bureau.
Research
The list of who your health records went to
The federal medical privacy rules create a right to an accounting of disclosures. What makes it useful is not the right itself but the nine categories it excludes, which is most of the traffic.
Research
What has to happen after a clinic loses your records
The federal medical privacy rules define a breach by presumption, then set a sixty-day clock, five things the notice has to say, and separate duties toward the media and the regulator that turn on population counts.
Research
When health data stops counting as yours
The federal medical privacy rules define a point at which information about a person stops being protected health information. There are exactly two ways to reach it, and one of them is a list of eighteen things to remove.
Research
The credit terms a seller may not take from you
A federal rule names four things a consumer credit agreement may not contain and one notice a cosigner has to be handed first. All five are about what happens if the payments stop, which is the part nobody reads at signup.
Research
The dispute panel a warranty can route you through
A written warranty can require a buyer to go through a private panel first. A federal rule sets out what that panel has to be made of, how fast it has to move, and what its decision is and is not worth.
Research
The notice a financed purchase has to carry
When a purchase is paid for with credit arranged through the seller, a federal rule requires a specific paragraph inside the credit contract. Its last sentence is the one that gets left out of every summary.
Research
The warranty terms a buyer can read before paying
A federal rule requires the text of a written warranty to be available before the sale, not after it. A companion statute forces the warranty to carry a one-word label saying whether it meets a federal minimum standard.
Research
What a bona fide offer to sell requires
Federal guides treat an advertised offer the advertiser does not actually want to fill as a distinct problem, separate from whether anything in the ad was false. The test they set is about what happens after the reader arrives.
Research
What a Made in the USA label has to be true of
A short federal rule sets three conditions for an unqualified American-origin claim, all of which have to hold at once. It also defines the claim broadly enough that a seal, a badge and a sentence of body copy are all covered.
Research
What a money-back guarantee has to refund
Federal guides set one standard for the phrase and it is unusually blunt: the full purchase price, at the purchaser's request. Everything that narrows it has to be disclosed in the advertisement that used the phrase.
Research
What an unsubscribe link has to do
The federal email rules put a clock on an opt-out, a floor under how long the mechanism has to keep working, and a hard ceiling on what a sender may ask for in exchange. They also decide which messages count as marketing in the first place.
Research
When a state health privacy law outranks the federal one
The federal medical privacy rules displace a conflicting state provision as a general matter, and then carve out four exceptions. One of them is a floor rather than a ceiling, and it is why the answer to a privacy question can differ by state.
Research
The conflict of interest rules on publicly funded research
Research paid for with public health funding carries a disclosure regime with a five-thousand-dollar threshold, an annual refresh, a written management plan and — unusually — a duty to publish some of it. It attaches to the funding, not to the science.
Research
The material a preclinical study actually tested
Before a regulated safety study generates a single number, the rules require the substance itself to be pinned down: identity, strength, purity, composition and stability, batch by batch, with a reserve sample kept and a label that carries the batch number.
Research
The money a trial investigator has to disclose
Federal regulation names four kinds of financial interest a clinical investigator has to declare, sets a dollar figure on two of them, and extends the clock for a year after the study ends. It applies at one specific moment, and outside that moment it applies to nothing.
Research
The release tests a licensed biologic has to pass
For a licensed biological product, four words carry legal definitions — safety, purity, potency and sterility — and no lot may leave the manufacturer before the tests behind them are complete. The sterility rule allows exactly one repeat, and only for a stated reason.
Research
The safety reports that continue after approval
Approval is not the end of the paperwork. A company holding an approved drug application files on three separate clocks — fifteen days, three working days, and once a year — and the fifteen-day clock is triggered by a word that depends entirely on what the label already says.
Research
The two roles a preclinical study cannot run without
Federal good laboratory practice names one person who owns a study end to end and one unit that is forbidden to work on it. The separation between them is the whole design, and it is why a study date is defined by a signature.
Research
What a preclinical final report has to contain
Federal good laboratory practice lists fourteen things a nonclinical study report must carry. One of them is a description of every circumstance that may have affected the quality or integrity of the data — a heading no journal article has.
Research
What happens after a research misconduct allegation
The federal procedure runs in four stages with two hard deadlines, and the first move is not an interview. It is taking custody of the records before the person accused knows there is an allegation.
Research
What makes an electronic laboratory record count
A number on a screen is not a record. Federal rules set out what an electronic system has to do before its output is treated as equivalent to a signed page — and the central requirement is an audit trail that cannot quietly overwrite what came before.
Research
What research misconduct means in the federal rules
The federal definition is narrower than the everyday phrase. It covers three acts, requires one of three states of mind, and has to be proven to a stated standard — and it explicitly excludes honest error and disagreement.
Research
When a testing laboratory is disqualified
Disqualification does not close a laboratory. It stops the laboratory's safety studies from counting — including studies already filed, already relied on, and already used to approve a product.
Research
Where the phrase "for research use only" comes from
That sentence is not a disclaimer someone invented. It is prescribed word for word in a federal labeling regulation — one written for a specific category of product, with a second sentence beside it for a different stage of development.
Research
Approved, off-label, unapproved, compounded
Four words describe four different legal states, and sales copy treats them as one. The most common swap is calling a compounded peptide an off-label prescription, which is a phrase that needs an approved drug to mean anything.
Research
How a drug rule gets made, and how a person gets heard
Anyone may ask the agency to write, change or scrap a rule, and anyone may comment on a proposal. The regulation is explicit that persuasiveness counts and volume does not.
Research
How compounded peptides are actually made
Almost every peptide sold through telehealth comes from a compounding pharmacy rather than a drug manufacturer. There are two kinds of compounding pharmacy, they are held to different standards, and knowing which one made your vial starts with the provider naming it.
Research
How the FDA bulk substances lists work
A compounding pharmacy cannot use just any powder. Federal law limits it to substances that clear one of three gates, and the lists that decide which peptides qualify are still being built, one nomination at a time.
Research
How this site grades the evidence
Every compound here carries one of three words describing the published human evidence behind the way it is sold. The word belongs to the compound and never to the seller, and the table below is generated from the same map the boards read.
Research
How to ask the FDA for a document
The rules on requesting an agency record set a twenty working day clock, three fee categories, a route for urgent requests and a written appeal deadline. Most of the leverage is in how the request is worded.
Research
How to read a certificate of analysis
A certificate of analysis is a test report on one batch, written by whoever made it. Most of the ones circulating in this market test purity and nothing else, which leaves out every measurement that matters for something you inject.
Research
How to read a peptide price
Two providers can advertise the same treatment at prices that look far apart and cost the same, or look identical and differ by half. The headline number is rarely the comparable one, and knowing which unit you are being quoted is most of the work.
Research
How to read a study cited on a peptide page
A citation under a product claim is doing one of two jobs: supporting it, or decorating it. Six checks separate them, and each one takes under a minute on the abstract alone.
Research
How to read an FDA drug label
A prescribing label is the one document that exists only for a compound with an actual FDA approval behind it. It follows a required structure, the same sections appear in the same order on every one, and reading three of them tells you more than any marketing page will.
Research
How to read an FDA warning letter
A warning letter is an allegation and an invitation to respond. FDA calls it informal and advisory, and says it is not final agency action, which is a long way from the verdict it is usually read as.
Research
Oral, nasal and topical peptides: what the route changes
Almost every approved peptide drug is injected, and the exceptions show why. The one semaglutide tablet on the market needed a built-in absorption enhancer to get roughly one percent of the dose into the blood, and it comes with instructions that are part of the product.
Research
Peptide half-life and the dosing schedule
Half-life is the clock inside a dosing schedule. Across approved peptide drugs it runs from under two minutes to about a week, and that spread is mostly engineering rather than biology.
Research
Peptide side effects: where the numbers come from
A side-effect percentage is only worth reading if you can see three things beside it: how many people it counted, what the comparison group did, and the cutoff below which nothing was printed. Most peptides sold today have no document that carries any of the three.
Research
Peptide storage and the cold chain
The storage numbers circulating for peptides come from chemical supplier data sheets, not from drug labels, and they differ enormously between compounds. Understanding what those temperatures protect against explains a shipping charge, a short use window, and part of what you are paying per milligram.
Research
Research use only: what that label means
A vial labeled for research use only is being sold as a laboratory chemical, not as a medicine. That single sentence carries the whole difference, because everything a prescription supply chain does to guarantee what is in a vial has been left out.
Research
The breach rule for health apps HIPAA does not cover
A separate federal rule requires notice when health information leaks from an app or online service outside the medical privacy law. It defines a breach to include an unauthorized disclosure, not just a hack.
Research
The change that forces a product to get a new number
A drug code is a version identifier as much as an identity. Six kinds of change require a new one, a seventh changes only part of it, and using the code to suggest approval can misbrand the product.
Research
The drug import route that is not for individuals
A federal regulation does authorize importing cheaper medicines from Canada. Reading who may apply, which drugs qualify and what testing is required shows why it has nothing to do with a parcel arriving at your door.
Research
The file that keeps an ingredient maker's secrets
A drug master file lets one company rely on another's manufacturing information without ever seeing it. The regulation also says, in one sentence, that the agency does not ordinarily review or approve what is in it.
Research
The file types FDA has already written a disclosure rule for
Instead of arguing every request from scratch, the agency published a table saying in advance what happens to each kind of document. It is a map of where drug information lives, and it is worth reading as one.
Research
The five people behind a laboratory result
Federal rules name the roles a laboratory has to fill before it may report a number, what each one has to have studied, and how often the director has to physically be there.
Research
The hearing a company gets before a fine
Between a letter and a lawsuit sits a whole administrative court, with a complaint, an answer, a burden of proof, a public hearing and an appeal. Missing one thirty-day deadline decides the case.
Research
The label box that says a claim is only possibly effective
A regulation still on the books requires certain drug labels to carry a boxed statement grading their own indications. It is a different box from the safety warning, and it grades whether the drug works.
Research
The language rules a health program has to follow
Where these rules apply, interpretation is free, a family member is not an acceptable interpreter, and machine translation of anything important has to be checked by a person. Whether they apply at all turns on one definition.
Research
The one injectable label that carries an aluminum number
Drug labeling rules almost never put a contaminant limit on a container. One section does, for one narrow class of injectable, and reading why shows how specific a labeling requirement has to be before it exists at all.
Research
The quality system behind an injector pen
The rules for making a medical device are no longer written out in the Code. They point at an international standard instead, and the parts that stayed behind say a lot about what the agency wanted to keep in its own words.
Research
The rules on a sales call, and the ones that stop when you dial
A federal rule tells a caller what it must disclose before you agree to pay and when it may call at all. Most of it switches off when you are the one who called, with one exception that matters.
Research
The test a laboratory has to pass three times a year
A lab that runs your blood panel sits a graded exam it cannot see coming, using the same staff and the same machines. The rules on how it sits that exam are stricter than the exam itself.
Research
The text messages a seller may send, and how to stop them
The federal telephone rules treat a marketing text like a robocall, define what counts as consent, and give the word stop a specific legal effect. They also bar a sender from deciding the only way you may opt out.
Research
The three-day cancel right, and where it does not reach
A federal rule gives buyers three business days to walk away from certain sales, with no penalty and no reason required. Its own definition section is what decides whether a purchase is inside it.
Research
The two lab certificates, and who actually inspects
A laboratory can satisfy the federal scheme by being inspected by the government or by a private accreditor. The paperwork looks similar. What the public can see afterward is not similar at all.
Research
The yearly list of laboratories that got into trouble
Federal rules require an annual public register of laboratories that were sanctioned, convicted, excluded or had a certificate pulled, with the reasons attached. It is one of the few registers built for the public rather than the regulator.
Research
Two compounds, one vial: what a peptide blend hides
A blended vial is sold as one product at one price, and it is two regulatory positions, two half-lives and two unstated amounts. The federal standard for combining drugs in one dosage form asks a question a blend listing almost never answers.
Research
What a combination product has to report
When one product is a drug and a device at the same time, two harm-reporting regimes point at it. Federal rules stack them, set a five-day clock between the companies involved, and stretch one deadline in a way worth knowing.
Research
What a company can keep out of a public file
Stamping a document confidential does not make it confidential. Federal rules set out what a submitter actually has to do, what the agency does when somebody asks for the file, and how many days there are to object.
Research
What a compare-at price is measured against
Compare at, retail value and manufacturer suggested price all claim something about what other people charge. Federal guidance sets a specific test for each, and the test is about where sales actually happen.
Research
What a crossed-out price has to be true of
A price with a line through it makes a factual claim: that the seller really charged that amount, openly, for a meaningful stretch of time. Federal guidance spells out what that claim requires, and it is more demanding than a design decision.
Research
What a peptide telehealth intake actually asks
The intake form is the appointment. It decides whether you are eligible, which clinician sees you, what you will be charged and what you have agreed to, and most of it happens before anyone reads a word you wrote.
Research
What a registered clinical trial tells you
An NCT number on a product page proves that someone filled in a form. Registration records what a study intends to do, and it is written by the sponsor rather than checked by anyone.
Research
What a supplement maker has to sample, and when
Testing a finished bottle is the last of five sampling points, not the only one. The supplement manufacturing rules name each one, and the earlier ones are where most of the real control happens.
Research
What has to be on the lab report you were sent
Federal rules list seven things a laboratory report must carry, name who may receive it, and say what happens when a number turns out to be wrong. Several of the items are ones people never think to look for.
Research
What it takes for a drug to be sold over the counter
Some medicines reach a shelf without an individual approval, by matching a published recipe instead. The rule that permits it lists conditions that all have to hold at once, and failing any one of them undoes the whole arrangement.
Research
What kind of lab can run the blood test you were sent
Laboratories are sorted by how hard their tests are to get right, and the certificate a lab holds decides which tests it may run at all. One category of testing sits outside the scheme entirely, and it is the one worth knowing about.
Research
What "peptide therapy" actually means
Peptide therapy is a marketing category rather than a medical one. The word covers everything from insulin to a vial labeled not for human consumption, which is why the phrase tells you almost nothing about what you are being sold.
Research
Are peptides steroids? What the legal categories actually say
The question has a clean answer, and the answer does not carry the reassurance most people are looking for. Federal law defines an anabolic steroid by its chemistry, and scheduling, approval and sport eligibility are three separate axes that a single compound can fail in three different ways.
Research
Do peptides show up on a drug test?
Two completely different tests share the word, and they give opposite answers. The federally regulated workplace panel is a closed list of five drug classes published in regulation. The anti-doping list is a different document entirely, and it names seven of the sixteen compounds tracked on this site.
Research
Insurance, HSA and FSA: why this is a cash-pay category
Coverage and tax-advantaged accounts run on two different tests, and most of this market fails one and can pass the other. The coverage question turns on approval. The account question turns on whether something was prescribed, which is not the same thing at all.
Research
USP chapters, sterility and beyond-use dating
A beyond-use date is not an expiration date. It is the point after which a compounded preparation should not be used, and its length is earned by testing rather than set by the molecule.
Research
What an asynchronous visit can and cannot assess
Store-and-forward care carries exactly what you sent and nothing else. That is its efficiency and its limit, and the two are the same property seen from different sides.
Research
What an HPLC purity number proves
A purity percentage is a ratio of what one detector saw in one sample. Four of the measurements that decide whether an injectable is safe are invisible to it, and a regulator writing rules for the same molecules asks for all four.
Research
What is in the vial besides the peptide
The active peptide is a small part of what is in an injectable. The rest is buffer, tonicity agent, bulking agent and sometimes a preservative, and one approved product shows how much difference those ingredients make by shipping in two versions.
Research
What makes a prescription valid
A prescription is not paperwork that follows a decision. It is the decision, and federal law describes it in terms of who wrote it rather than what it says.
Research
What registering with the FDA actually confers
A facility that makes drugs has to tell the FDA it exists. The regulation that governs that filing also says, in its own words, what the filing does not mean, and it uses the word misbranding for claims that suggest otherwise.
Research
What the FDA will and will not release about a company
The agency has a written rule about its own files. It starts from disclosure, lists eight categories it may withhold, and then lists the situations in which those categories stop protecting anything.
Research
When a labeling exemption runs out
Several containers in the drug supply chain legally carry no usable directions. Each exemption that permits that has an end point written into it, and one of them is retroactive.
Research
When a pen is a drug and a device at once
An autoinjector is two regulated things in one object. Federal rules say which manufacturing rulebook applies, and they let a maker satisfy both sets without running two parallel quality systems.
Research
When a provider stops serving your state
A service map is a licensing artifact, and it can change without anything changing about you. What stops, what continues and what you can still retrieve are three separate questions.
Research
Where a peptide prescriber has to be licensed
The state you type into an intake form is not a shipping field. It decides which clinicians may legally treat you, and it is settled before anyone reads a word of your health history.
Research
Counterfeit and gray-market supply
Counterfeit product and gray-market product are two different failures, and only one of them involves anyone lying about what is in the vial. The distinction changes what you can check.
Research
How to check a prescriber's license and NPI
Two public registers exist, they answer different questions, and only one of them says anything about a license. The registry that everyone reaches for first says in its own words that it does not.
Research
How to read a study run by the seller
Industry funds most clinical research, and sponsored trials are not run worse than other trials. The measured difference sits between a study's results and the sentence its authors wrote about them.
Research
Ordering peptides from overseas: what the import rules say
There is a widely repeated belief that a personal three-month supply is allowed into the country. What actually exists is an agency discretion policy that says in writing it is not a license to bring anything in.
Research
What a medical advisory board is and is not
No agency licenses, registers or defines the term. What does exist is a set of advertising rules about what an expert endorsement has to be backed by, and they are more demanding than the phrase suggests.
Research
What a trial endpoint actually measures
An endpoint is the thing a trial measured. Whether it is the thing you care about is a separate question, and FDA keeps a public list of the substitutes it has accepted because the answer is so often no.
Research
Who decides whether a product is a drug or a device
When something could be either, one office inside the FDA picks which center reviews it. The rule that governs that choice turns on a single question, and it gives the applicant a route to ask first.
Research
Why animal data does not transfer to people
Animal work is where hypotheses come from. FDA divides a rodent result by a species factor and again by a safety factor before anyone gives a first human dose. A review of six treatments found the animals and the patients pointing in opposite directions twice.
Research
Peer-reviewed, preprint, or conference abstract
Three things that all look like studies when a product page links them. One has been checked by outside experts, one has not, and one is a summary that more than half the time disagrees with the paper it becomes.
Research
What a mechanism claim can and cannot predict
A story about how something works is a reason to run a trial, not a result from one. Federal drug labeling keeps the two in separate sections, and lets one of them say the mechanism is unknown.
Research
What a systematic review adds
It is not a longer opinion piece with more citations. A systematic review commits to its question before it looks, searches for everything including the studies nobody published, and rates what it finds.
Research
What "clinically studied" means on a product page
The phrase has no fixed definition, so it means whatever a reader takes from it. Under federal advertising law, what the reader takes from it is the claim the seller has to be able to prove.
Research
What has to happen before a first human dose
Before a new compound is legally given to a person in the United States, a specific sequence of permissions has to be in place. Knowing the sequence explains what is missing when a compound is sold without it.
Research
Why a twelve-person study cannot carry a population claim
A small study is not a small version of a big one. Below a certain size a positive result becomes less likely to be true and more likely to be exaggerated, which is the opposite of how most people read one.
Research
What a dispensed drug label has to carry
The sticker on the box is a legal instrument with a short, published list of contents. Reading your own against that list is the fastest way to learn who actually filled your order.
Research
What a pharmacy accreditation actually means
An accreditation seal is a private organization saying a pharmacy met its published standards. No federal compounding rule requires one, and it is a different thing from the license that does.
Research
What an NDC is, and why a compounded vial may not have one
The national drug code is an inventory identifier that FDA says is not an approval, not a verification and not proof a product is even a drug. Its absence on a compounded preparation is expected.
Research
What authorizes a refill
In federal law a refill is an act of the prescriber, recorded. In this market the word usually names a recurring charge. Those are two different instruments that happen to share a noun.
Research
What happens to your records when a seller disappears
The federal right to a copy of your health information runs against a specific kind of organization, covers a specific set of documents, and lasts exactly as long as those documents are kept.
Research
Where a side-effect report actually goes
There is a federal system for collecting reports of harm from medical products, and there are published rules about who must file into it. Most of this market sits outside those rules.
Research
Prescription, supplement, or research chemical
Three kinds of seller use the same product photography and the same vocabulary. Federal law puts them in three different categories with three different sets of duties, and the tells are printed on the label.
Research
The questions this market does not answer
Some questions about a seller can be settled from a public page in a minute. Others cannot be settled at all, and the split between the two is not random. It follows where a duty to publish exists.
Research
What a recurring charge commits you to
Most people picture a federal cancel-in-one-click rule standing behind an online subscription. What governs the charge is a much shorter statute, and the load-bearing word in it is before.
Research
When an order does not arrive, or arrives wrong
Two separate systems answer this. One governs the shipping promise, the other governs the charge on your statement. They run on different clocks, they need different paperwork, and neither one starts by itself.
Research
How a label gets onto the right container
A vial with the wrong label on it looks exactly like a vial with the right one. Federal manufacturing rules treat labels as a controlled material for that reason, and the controls are specific enough to ask about.
Research
How a study gets stopped, and who can stop it
Four separate mechanisms end or suspend an investigation, and they belong to different parties. Reading the grounds is the fastest way to understand what a registry status field is not telling you.
Research
The FDA letter that is not a warning letter
Below the warning letter sit two quieter instruments with different thresholds, different wording and different publication rules. A search that finds no warning letter has checked one page out of several.
Research
What a card dispute can reach that a refund request cannot
Two separate rights sit on a credit card, and only one of them is about whether the seller did what it promised. That one starts with a conversation you have to have first, and it stops short of deciding who is right.
Research
What a checkbox at checkout actually signs
Nobody hands you a pen, so it is easy to read the tick box as a formality. A federal statute treats it as a signature, sets out what has to be said before you tick it, and then names the notices it will not carry.
Research
What a comparison site cannot check for you
Everything on a comparison page was read from the outside, from pages sellers wrote about themselves. That sets a hard limit on what any of it can settle, and it leaves a short list of checks only a buyer can run.
Research
What a complaint about a medicine is supposed to trigger
Writing to the company that made something feels like the weakest move available. In the federal manufacturing rules a complaint is a document with a procedure attached, and one requirement is a written reason for deciding not to look into it.
Research
What a compounding exemption actually exempts
Federal law lifts three named requirements from a compounded prescription, and only while a list of conditions holds. The exemption is narrow, it is conditional, and the conditions are the part a buyer never sees.
Research
What a free consultation is priced into
A free visit, free shipping and a free first month are three different offers, and the word free carries a specific claim about the price of whatever you do pay for. The Federal Trade Commission has written that claim down, and it is more demanding than most readers expect.
Research
What a laboratory-only shipment has to carry, and who it may go to
The investigational drug rules contain one section about material shipped solely for tests in animals or in glassware. It prescribes a caution, a duty to check the recipient, a shipment record and a way for the agency to switch the whole arrangement off.
Research
What a peptide sequence settles, and what it leaves open
A sequence of amino acids is the most precise thing a product page can print about what is in a vial. It fixes the substance, and it still leaves the article you are buying undecided in four separate ways.
Research
What a rank on a board is actually ordering
A first row reads as a recommendation. It is the output of a sort with three keys, and the third one is not what most readers would guess.
Research
What a score out of ten is actually counting
A number beside a seller looks like a measurement of the seller. On this site it is six yes-or-no facts divided by six, and knowing that changes what the number can be used for.
Research
What a seller can do with your information after you buy
An intake collects a medical history, a payment method and a shipping address. Two very different documents govern what happens to that afterwards, and most people sign one while thinking about the other.
Research
What a stability program has to test
A date on a medicine is the output of a written testing program, and the federal rules list what that program has to include. Two of the five requirements are about the container and about anything you mix yourself.
Research
What a strength on a vial actually states
The number printed on an injectable can answer either of two questions: how much drug is in the container, or how much is in each milliliter of it. Both are called the strength, only one of them is the denominator a price comparison needs, and FDA has published that compounders and manufacturers do not always choose the same one.
Research
What a study run in another country has to satisfy here
Much of the human research behind this market was done somewhere else. FDA has written down what it takes for such a study to count in an application, and the conditions are short, specific and public. They are not a rule about websites, which is exactly why they make a useful checklist for reading one.
Research
What a study without blinding is also measuring
In an open-label trial, everyone knows who got what. That is a real design choice with a measured cost, and the size of the cost depends almost entirely on how subjective the thing being measured is.
Research
What a trial does when someone is harmed
A separate reporting system runs inside a study, with its own definitions, its own clocks and its own destination. It measures the word unexpected against a document most people have never heard of, and almost nothing it produces is public.
Research
What a trial has to tell the person in it
Federal regulation lists what a research subject must be told before agreeing, and it names fourteen separate items. One of them is a sentence about the public trial record, written out word for word in the rule.
Research
What a trial registration record has to contain
A registry entry is a form with a fixed set of boxes, and federal regulation names every box. Knowing which ones exist tells you what a citation to a registered trial can and cannot be hiding.
Research
What a USP or pharmaceutical-grade claim commits a seller to
Pharmaceutical grade is a sales phrase with nothing behind it. USP is different, because the moment a product borrows a name a pharmacopeia recognizes, federal law attaches a standard the product then has to meet.
Research
What adulterated means, and what it does not require
The federal drug law reaches the word adulterated on a list of named grounds. Half of them are written about devices, none of them requires anyone to have been harmed, and one of them turns on an answer given at a factory door.
Research
What an endotoxin limit is, and why sterile is not enough
Sterile and pyrogen-free are two claims, tested two ways. An endotoxin result only means something with a limit printed beside it, because the limit is calculated from how much of the product a person receives.
Research
What an outsourcing facility registration commits a facility to
The second compounding category is entered by choice, and choosing it swaps a lighter set of duties for a heavier one. The clearest way to read the badge is as a list of obligations rather than an award.
Research
What enforcement discretion actually is
It is a statement about what an agency currently intends to do, written in a document that binds nobody, and it leaves the underlying law exactly where it was.
Research
What expanded access and right to try actually require
Two federal routes let a person receive a drug that is not approved. Both are written down, both are narrow, and both open on the same kind of finding about a disease. Reading them is the fastest way to see what an ordinary online purchase is not.
Research
What happens after a drug is called misbranded
Adulterated and misbranded are conclusions written into the federal drug law, and the same law says what follows from them. It names the acts that are forbidden, the three things a court can be asked to do, and the one party allowed to ask. That last sentence is the one almost nobody quotes.
Research
What happens to a vial that goes back
Returned medication has its own short subpart in the federal manufacturing rules, and the default written into it is destruction. What it takes to keep a returned product is spelled out, and so is what a fire or a flood does to the stock around it.
Research
What happens to the powder before it becomes a medicine
A vial starts as material somebody received on a loading dock. The federal manufacturing rules give that arrival its own subpart, and the requirements begin before any laboratory is involved.
Research
What happens when a trial never reports its results
A registered study with no results is common, and federal law does not treat it as nothing. There is a deadline, two lawful ways to be late, a penalty route, and a notice the registry itself has to carry.
Research
What happens while a batch is being made
A certificate describes the end of a process. The federal manufacturing rules spend most of their attention on the middle, and one of them says outright that the controls exist to validate the process rather than to check the product afterwards.
Research
What kind of name is on a peptide vial
A drug can carry five different kinds of name, and only two of them are issued by anybody. Most of what this market sells carries neither, which is why the same substance turns up under several names and none of them is authoritative.
Research
What makes a label statement count as being on the label
Federal drug labeling rules are not only about what a label says. They also set how visible a required statement has to be, what language it has to be in, and where it may sit when the container is too small to hold it.
Research
What may be said, labeled and charged for a drug still in trials
Three short regulations sit at the front of the investigational drug rules. They fix the words on the package, forbid the people running the study from promoting it, and cap any charge at audited direct cost. None of them binds a website, which is exactly what makes them a useful ruler.
Research
What paperwork comes in the box, and what has to
The leaflet in a package is regulated separately from the medicine in it. Federal rules say when one is required, what it has to say, whose job it is to hand it over, and what your own container label should tell you about it.
Research
What period a monthly price actually covers
Two sellers can both publish a figure they call monthly and be describing periods of different lengths. One is a calendar month, one is four weeks, one is however long a container lasts, and one is a fixed course divided out. Until you know which, the numbers are not set against each other.
Research
What recourse looks like when no company is named
Every route to a remedy starts by naming somebody. A licensing board acts on a licensee, a court needs a defendant, and a card issuer wants to know you tried the seller first. Some sellers in this market publish no company at all.
Research
What statistically significant does and does not say
The phrase answers one narrow question, and it is not the question most readers think. It says nothing about how large an effect was, how useful it would be, or how many other things were measured first.
Research
What stops one drug getting into another
A facility that makes several products has to keep them out of each other. The federal rules handle almost all of that with procedure and defined areas, and then single out one drug for a separate building, separate air and a mandatory test.
Research
When a medicine is recalled, and how you would hear
A recall is a company removing its own product, and the notice travels only as far down the chain as a written strategy sends it. A public announcement is the exception, not the rule.
Research
When a product changes its name
A name is the key to almost everything you can look up about what you are buying. Change the name and every lookup comes back empty while the vial stays the same, and the federal rules that keep a name honest mostly stop before the vial reaches you.
Research
Where the manufacturing rules stop
One short section decides how far the drug-manufacturing rulebook reaches. It stacks rulebooks instead of choosing between them, lets a company answer only for the steps it performs, and switches one rulebook off while leaving the statute behind it standing.
Research
Who actually oversees the pharmacy that made your vial
Two regulators stand behind a compounded preparation and they do different jobs. The federal agency says in its own words that it approves and licenses no facility, and that states handle day-to-day oversight of most compounders.
Research
Who answers for a trial, and what they have to keep
A study has two named duty-holders, and one subpart of the investigational drug rules sets out what each of them signs, ships, checks, records and returns. It is the paper trail that makes a trial answerable, and it has no equivalent in an ordinary sale.
Research
Who can actually make a seller answer
Reading a consumer rule leaves the impression that breaking it hands you something. Read the enforcement sentences instead and a different picture appears: most of these rules name a government plaintiff, and the claim that is yours runs against your bank rather than the seller.
Research
Who ran the test, and what third-party tested means
Third-party tested names a relationship, not a result. The federal manufacturing rules are unusually specific about when one company may rely on another company's test, and the conditions they attach are the ones a marketing phrase leaves out.
Research
Who was still in the study at the end
Enrollment and analysis are two different numbers, and the second one is smaller. The rules behind real trials say who is supposed to count, and researchers have measured what the missing people could do to an answer.
Research
Why a manufacturing failure makes a drug adulterated
A three-section regulation sits in front of the long manufacturing rulebook, and one sentence in it does all the work. Failing any rule in that rulebook renders the drug adulterated, and makes the person responsible separately answerable.
Research
Why a prescription label carries no directions you can follow
Federal law requires a drug label to bear directions a non-specialist could act on. Prescription drugs are exempt, and the whole shape of a prescription package is the price of that exemption.
Research
When a study of an approved drug needs no permission
Not every clinical study needs federal clearance. A study of a medicine already on the market can be exempt, but only if five conditions all hold at once, and one of them is about risk rather than paperwork.
Research
What happens when a company hands its duties to someone else
Drug sponsors are allowed to outsource almost anything, including their legal obligations. The rule that permits it also decides what happens to the parts nobody wrote down, and the default runs against the company doing the handing.
Research
What has to be true before an unapproved drug leaves the country
A drug still under investigation can be shipped abroad, and federal regulation sets out exactly how. One of the routes requires the shipper to affirm eleven separate things in writing before the first package moves.
Research
What a drug company and the regulator say to each other
Most of the relationship between a sponsor and the agency is conversation, not decisions. Two sentences in the rules govern what that conversation is worth: one says advice binds nobody, the other says a written agreement does.
Research
The document a trial doctor reads before the first patient
Every investigator in a drug trial is handed one document before the work starts, and signs to say they have read it. Federal regulation lists exactly what is in it, and the list is a fair standard to hold any product page against.
Research
What a company keeps telling the agency while a study runs
Permission to test a drug in people is not a one-time event. It opens a file that has to be fed, on defined channels and defined clocks, for as long as the work continues.
Research
What changes between phase 1 and phase 3
The phases of a drug trial are usually described by how many people are in them. The regulation describes something more useful: what each stage is asking, and how much a company owes the regulator at each one.
Research
How a drug for a fatal illness is developed differently
Federal regulation carries a separate, faster route for drugs aimed at illnesses that kill or permanently disable. It changes meetings, timing and the weighing of benefit against risk. It changes none of the safety requirements, and it says so in its own last section.
Research
Everything a company files before a drug is tested in people
The application that opens a human trial has a contents list written into federal regulation: eleven numbered items in a fixed order, down to how the pages are numbered. Reading it shows what a regulated claim rests on.
Research
The words a drug trial uses, and who they point at
Sponsor, investigator, subject, study. In marketing these words are loose. In the federal rules on investigational drugs each one is defined, and each definition attaches a different set of obligations to a different person.
Research
What a customer review is allowed to imply
A testimonial about how well something worked is read as a claim that it works. Federal advertising guides put the burden of proving that claim on the seller, not on the customer who wrote it.
Research
The label that lets you treat yourself
An over-the-counter label is the one document designed to work with no professional in the loop. Federal regulation specifies its headings, their order, and the exact words several of them must use.
Research
When a supplement claim becomes a drug claim
A supplement may describe what an ingredient does in the body, but not what it does to a disease. Federal regulation sets out how that line is drawn, and it is more detailed than most sellers expect.
Research
How a study drug under the drug control laws is kept
When a research drug falls under the controlled substances law, a second agency's rules attach to it. They are about locks, registration and reporting a loss, and they are strikingly physical.
Research
The one trial a person can be in without agreeing to it
Federal rules allow a single narrow exception to informed consent, for research in emergencies. The conditions on it are the clearest published statement of what serious research actually costs.
Research
What a peptide sold as a cosmetic is held to
Peptides turn up in creams and serums, sold under the cosmetic rules rather than the drug rules. Those rules ask less about whether a product works, and more about what its label has to admit.
Research
What a drug advertisement is not allowed to do
Federal regulation lists, one by one, the ways an advertisement for a prescription drug can mislead. The list reads like an inventory of the moves you see every day on a product page.
Research
Who a prescription drug may lawfully be sold to
A separate body of federal law governs the trade in prescription drugs before they reach a patient. It restricts who may resell them and requires a paper trail when the seller is not the maker's own distributor.
Research
The line where a peptide becomes a biologic
Federal law draws a size line through the middle of this market. On one side a product is an ordinary drug, and on the other it needs a biologics license, and the line moved in 2019.
Research
The manufacturing rules a supplement is actually held to
Supplements have their own good manufacturing practice rulebook, separate from the one for drugs. It demands a great deal on paper, and one of its central tests is weaker than most buyers assume.
Research
What a cell or tissue product is, and why exosomes are not one
A separate federal rulebook covers products made of human cells and tissue. Understanding which side of its line something falls on tells you whether it needed approval before it was ever sold.
Research
The two documents behind a supplement batch
A product sold as a dietary supplement is supposed to have a written recipe made before the batch, and a written record made during it. Neither one is on the label, and the rules name only one reader for them.
Research
Who has to say yes before a supplement ships
The supplement manufacturing rules give one function the power to release a batch, and a shorter list of batches it is forbidden to release. Failing a specification is not a judgment call about whether to ship.
Research
What a human tissue donor has to be screened for
Products made from human cells or tissue carry a rule about the person they came from. A named individual has to decide the donor was eligible, and until that decision exists the product may not be used.
Research
The manufacturing rules behind a tissue-derived product
Human cells and tissue carry a manufacturing rulebook of their own, built around one goal rather than product quality in general. Its sharpest line forbids mixing material from two donors at all.
Research
The count a controlled substance business has to take
Anyone registered to handle controlled substances owes two things: a running record of every movement, and a physical count at least every two years. An online pharmacy owes a monthly report on top of that.
Research
The label a bulk drug substance is supposed to carry
Drug labeling law lets a container skip directions for use in a few defined situations. Two of them cover bulk material and laboratory work, and each prescribes its own wording and its own conditions.
Research
The electronic trail a drug package has to carry
Federal law requires three documents to move with a prescription drug at every change of ownership, and a barcode on the package that ties a unit to a lot. None of it is addressed to a patient.
Research
When a seller puts its label on someone else's supplement
The supplement rules have a category for finished product bought from another company and labeled as your own. It comes with an examination on arrival, a quarantine, and an identifier that reaches back to the supplier.
Research
What a tissue product register actually records
Establishments handling human cells and tissue file a public registration and a product list. The list asks each company to state its own legal position about each product, and acceptance settles nothing.
Research
The filled container that has no label yet
A supplement can be finished, sealed and sitting on a shelf before anyone decides whose name goes on it. The rules address that gap directly, and the way they do it explains a lot about the market.
Research
The building a supplement is made in
The physical plant rules for dietary supplements reach the parking lot, the plumbing, the light bulbs and the trash. Three sections, and one of them is mostly a list of ways a building can contaminate a product.
Research
The equipment a supplement is made on
Calibration before first use, a thermometer in every cold room, and a rule that an instrument which cannot be brought back into agreement gets repaired or replaced. The equipment subpart is where a lot of the checkable detail lives.
Research
The order that can stop a tissue establishment
For human tissue products, the agency does not have to ask a firm to recall. It can order retention, recall, destruction, or a halt to manufacturing, and in a danger case the order is effective immediately.
Research
The paperwork that travels with a tissue product
Three things have to accompany a human tissue product at all times, and one of them is a summary of the records behind the donor decision. The label carries a fourth set.
Research
The quality program behind a tissue-derived product
The tissue rules do not stop at clean rooms and test results. A separate layer requires a named quality program, trained people, written procedures approved before use, and a decade of records.
Research
The shortest rules on a supplement factory floor
The subpart governing supplement manufacturing operations is six sections long and four of them are a single sentence each. Almost all of the substance sits in one list of eleven precautions.
Research
The label rules written because of weight loss
Two drug classes carry a boxed warning that exists for one reason: they were being prescribed for obesity. The regulation says so in its own first sentence, and a third rule dates to 1941.
Research
The audit trail behind an electronic prescription
For a controlled substance prescribed electronically, the record is not the prescription. It is a digitally signed copy, an internal audit trail, an identity-proofing record, and a set of third-party audit reports.
Research
What a tissue product complaint has to set off
A complaint about a tissue-derived product is the front end of a reporting chain. Two clocks can start from it: fifteen calendar days for a serious adverse reaction, forty-five days for a manufacturing deviation.
Research
What an online pharmacy has to post on its own homepage
Where controlled substances are sold online, the rules require a named list of disclosures on the homepage or one click from it — including the pharmacist-in-charge and every prescriber under contract.
Research
What happens to a supplement that comes back
The default for a returned dietary supplement is destruction. Salvage and reprocessing are exceptions that require a named decision, and one return can force an investigation into batches nobody complained about.
Research
What happens when drug samples go missing
A prescription drug sample that is lost or stolen starts a five-working-day notification clock and a mandatory investigation. There is also a reward for information leading to a conviction.
Research
When a tissue process changes, what has to be proven again
A claim that a process reduces disease risk has to rest on a verified or validated process. Change the process and the rules make you go back and show it still holds.
Research
Who is allowed to touch a supplement batch
The supplement manufacturing rules open with people, not machines. Five short sections cover who must be excluded, who must be qualified, who supervises, and what has to be written down about training.
Research
Whose name is on a drug package
A name printed alone on a drug label is a claim to be the sole manufacturer. The regulation lists the eleven operations that claim requires, and the exact phrases a distributor has to use instead.
Research
Why an exported American drug cannot simply come back
A prescription drug made in the United States and shipped abroad may be reimported by nobody except its own manufacturer. The one exception is emergency medical care, and it runs through a district office.
Research
Why two prescription labels look nothing alike
Two different labeling formats are in force at the same time, and which one a drug uses depends on when its application was filed. The older format carries a rule about laboratory and animal data that the newer one handles differently.
Research
What both sides hand over before a penalty hearing
The discovery rules in an FDA money-penalty case are narrower than most people expect. There are no interrogatories, depositions are rare, and a name left off one list can silence a witness.
Research
Who runs a penalty hearing, and what an appeal can change
One official decides an FDA money-penalty case, with nineteen listed powers and one large limit. The appeal that follows can raise the penalty as easily as lower it, and nobody gets to argue in person.
Research
Who else gets to see what a company told the FDA
A file can be withheld from the public and still be shared with a state inspector, a foreign regulator, a contractor or a congressional committee. The rules name each recipient and the conditions attached.
Research
What the FDA publishes without anyone asking
A quarterly index, a reading room and a rule that anything requested three times gets posted. Knowing what is already out there is usually faster than filing for it.
Research
The order form behind a controlled drug shipment
For the two tightest drug schedules, a numbered federal form has to change hands before anything ships. It expires in sixty days, cannot be corrected, and names one supplier and one delivery address.
Research
What changes when a controlled drug order is electronic
The electronic version of a schedule II order keeps the sixty-day clock and adds a certificate check, a two-business-day report, and a rule that no supplier may pass the order along.
Research
The exceptions written into the drug control rules
One short part of the controlled substance rules collects the carve-outs, including the telemedicine prescribing authority that the regulation itself says ends on the last day of 2026.
Research
Asking the FDA to think again, and to hold off
Two petitions sit between a decision and a courtroom. One asks for reconsideration on the existing record only. The other asks the agency to pause, and skipping it can cost a party its request in court.
Research
When the FDA sits on a standards committee
Agency staff take part in setting outside standards, under written conditions. The central one is that taking part is not agreement, and a participant is barred from later deciding on the standard.
Research
The record a meeting with the FDA leaves behind
Anyone may ask for a meeting. What survives it is governed by rules on what goes in the file, what a memo may say, who appears on a weekly public calendar, and when private contact becomes forbidden.
Research
How a guidance document is made, and how to push back
Guidance sorts into two levels, and only one gets comment before it takes effect. The rules also list what every guidance must say, four words it may not use, and who to call when it is treated as binding.
Research
The chain of custody behind an imported Canadian drug
The import rules build a closed loop: manufacturer to one seller to one importer, a serial number added on blank label space, a warehouse within thirty miles of the port, and six years of records.
Research
What a state has to file before it can import a drug
The application runs to a criminal history disclosure, seven years of disciplinary actions, five years of inspections, an annotated label comparison, and a cost-saving case built to be checked.
Research
The paperwork behind a nondiscrimination promise
Where these rules apply, a posted promise is backed by a named coordinator, five written procedures, three years of grievance records, and training documented as it happens.
Research
Accessible software, and the rule on care algorithms
One rule requires a covered health program's websites and apps to be accessible. A newer one requires it to go looking for decision tools that use race, sex, age or disability as an input.
Research
The controls a laboratory runs before it reports a number
Known samples run daily alongside yours, calibration verified twice a year, and a rule that a failed control forces a look back at every result since the last good one.
Research
The microscope test your own clinician is allowed to run
A short federal list lets a clinician look at your specimen under a microscope during the visit, without a full laboratory. The conditions on it explain why the list is short.
Research
How a laboratory certificate fee is actually set
The amounts are not in the regulation. What is in it is the method: eleven volume schedules, a test counted analyte by analyte, and an inflation formula with a catch-up clause.
Research
The hundred slide day, and the five year look back
Federal rules cap how many slides one person may read in a day, count that cap across every employer, and require a laboratory to reopen five years of negative results when a serious finding appears.
Research
Who grades the exam a laboratory has to pass
The organizations that test laboratories are themselves approved, on written criteria: a minimum participant count, a defensible way of deciding the right answer, and an attestation the laboratory director signs.
Research
Why research-use-only sellers are not compared here
A large parallel market sells the same molecules with a label saying they are not for human use. This comparison does not rank those sellers, and the reason is what the boards claim to measure.